The record

LegislationLegislation· Jul 2024
S 150

Sponsored by John Cornyn (R)

Affordable Prescriptions for Patients Act of 2023

Would have capped how many patents original biologic drug makers can use to block cheaper biosimilar (copycat biologic) drugs.

Tradeoff

Would have limited patent lawsuits against biosimilar (copycat biologic) makers. Would also have changed funding for the (federal health insurance for people 65+ and people with long-term disability) Improvement Fund.

What's in it

See official bill text
S. 150, Affordable Prescriptions for Patients Act of 2023www.cbo.gov/publication/60412 · Jun 2024

Passed the Senate by on July 11, 2024. The House never voted on it before the Congress ended.

  1. Senate

    Introduced

    (Jan 30, 2023)

  2. Senate

    Committee on the Judiciary(Jan 30, 2023)

  3. Senate

    The Committee on the Judiciary voted to send it to the floor

    Reported(Feb 9, 2023)

  4. Senate · Amended

    Senator Cornyn's

    Agreed to by (S.Amdt. 2399 · Jul 11, 2024)

    Removes the product hopping section that set FTC limits on certain drug switches, and adds a Medicare Improvement Fund change using $0 and $1,800,000,000 amounts.

    No individual votes were recorded.

  5. Senate

    Passage of the bill

    Passed by (Jul 11, 2024)

    No individual votes were recorded.

  6. House

    Received from the Senate

    Received(Jul 15, 2024)